Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Physician Assistant - 0.25 AAPA hour(s) of Category I credit
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for obstetricians/gynecologists/women's health clinicians, family medicine/primary care clinicians, internists, nurses, physician assistants, and other members of the health care team who treat and manage patients considering or undergoing hysterectomy for benign conditions.
The goal of this activity is for learners to be better able to describe the development, validation, and performance of multivariable logistic regression models to predict major complications of laparoscopic or abdominal hysterectomy for benign conditions.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 11/23/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 11/23/2022
Valid for credit through: 11/23/2023, 11:59 PM EST
processing....
Hysterectomy is one of the most frequently performed surgeries. The proportion of laparoscopic hysterectomies has increased substantially in many countries during the last decade, as clinicians and patients prefer minimal access approaches.
National guidelines recommend that the patient and surgeon discuss the chosen surgical approach, considering relative benefits and risks. Most surgeons can intuitively identify patient factors that may increase surgical complexity and complications, but a more standardized approach could help inform clinical decision-making.
An online prediction tool provides personalized risk estimates to help clinicians and patients choose between laparoscopic and abdominal surgery for hysterectomy for benign disease.
The tool, which integrates 11 routinely available predictors, had "acceptable" predictive ability and "moderate" discrimination.
"The overall numbers of hysterectomies are declining, and there are also more surgeons with smaller caseloads in the United Kingdom, and we felt the tool might help surgeons advocate for things that may make surgery safer," PhD student Krupa Madhvani, consultant obstetrician and gynecologist at the Royal London Hospital, United Kingdom, told Medscape Medical News. "These things include extra [operating room] time, extra surgical expertise, referral to regional centers, and robotic surgery for more complex cases, which is usually reserved for cancer cases in the UK."
The tool, which includes models for laparoscopic and abdominal surgery, is available online.
The study was published October 3 in the Canadian Medical Association Journal.
Dr Madhvani and colleagues analyzed routinely collected data from the English National Health System from 2011 to 2018. They identified major complications of laparoscopic and open abdominal surgery for hysterectomy for benign disease based on postoperative outcomes. After exclusions for malignancy and other factors, data from 68,599 patients who underwent laparoscopic hysterectomy and 125,971 patients who underwent abdominal hysterectomy were included in the models.
Multivariable logistic regression prediction models were based on the following 11 predictors: age, ethnicity, obesity, diabetes, fibroids, menstrual disorders, endometriosis or pain, adenomyosis, benign adnexal mass, adhesions, and other.
Major complications occurred in 4.4% of laparoscopic and 4.9% of abdominal hysterectomies. The models showed consistent discrimination in the development cohort (C-statistic: laparoscopic, 0.61; abdominal, 0.67), and similar or better discrimination in the validation cohort (C-statistic: 0.67 for both).
Adhesions were the strongest predictor of complications in both models.
In the laparoscopic model, adhesions (adjusted odds ratio [aOR], 1.92) and adenomyosis (aOR, 1.46) were associated with increased risk for major complications. In contrast, menstrual disorders (aOR, 0.75), benign adnexal masses (aOR, 0.85), and other gynecologic diagnoses at the time of hysterectomy (aOR, 0.87) were associated with protection against major complications.
In the abdominal model, adhesions (aOR, 2.46), Asian ethnicity (aOR, 1.40), and diabetes (aOR, 1.16) were associated with increased complication risk. Protective factors included benign adnexal masses (aOR, 0.79), fibroids (aOR 0.75), menstrual disorders (aOR, 0.52), and other gynecological disorders (aOR, 0.78).
The authors write, "Although a surgeon's experience and expert opinion carries utility, it cannot be used solely to guide risk management. [O]ur models could be useful tools to stratify risk."
Dr Madhvani added, "The next steps would be to see how the individual experience of the surgeon can improve this model. Evidence from observational studies shows that this has an impact on conversations from laparoscopy to laparotomy and complications."
She suggested that clinicians "explore the tool to see if the risk prediction matches your own intuition when estimating the risk of complications for patients on an individual level."
Commenting on the study for Medscape Medical News, Jonathan Schaffir, MD, medical director of the Obstetrics and Gynecology Outpatient Clinic at Ohio State University Wexner Medical Center in Columbus, said that the tool will not significantly aid counseling for patients who are undergoing hysterectomy. Dr Schaffir was not involved in the research.
It is important that patients understand the risks of surgery, he said. "But it is unlikely that a numerical value for the rate of complications will significantly affect the choice to have surgery. The recommendation for surgery and the decision as to the best route is dependent on many individualized factors that are not covered by this tool, and ultimately each person undergoing hysterectomy will have to make the decision for herself whether perceived benefits outweigh the risks."
For example, he noted, "The authors do not consider thromboembolism or wound infections treated with antibiotics to be complications in this algorithm. These are some of the most common complications that we see, so I would certainly want my patients to know their risks of these issues in advance."
In addition, he said, "some factors that are examined as a risk are poorly defined. Obesity was a yes or no response, but clearly the complication rate is much higher for a woman with class III obesity compared with a woman who is slightly obese. Similarly, fibroids are placed in a single category, but the difference in doing surgery for a woman with small incidental fibroids vs one whose fibroids make her look 7 months pregnant is vast and would be expected to have very different risks."
In the study, fibroids were associated with a protective effect, he added, "which does not make sense, given the significant distortion of anatomy that may be present with large fibroids."
"I would want to see more research of patient perceptions and opinions," Dr Schaffir said. "Is there a risk value for which a particular set of patients would decline surgery? What information would they want to know that would persuade them to have one route of hysterectomy vs another? Unless there is a clear use for having a numerical prediction, I don't think the tool is practical."
Data acquisition was funded by the British Society for Gynaecological Endoscopy. Dr Madhvani has received article processing fees from East London International Women's Health Charity. Dr Schaffir has disclosed no relevant financial relationships.
CMAJ. Published online October 3, 2022.[1]